Ron SCHLINGER
11Patents
1h-index
15Co-inventors
43Inventor score
Filing activity: Jun 18, 2015 → Sep 29, 2021
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US10548837B1 | Topical montelukast for treatment of atopic dermatitis | Human Necessities | 4 | Active |
| US11446237B2 | Stable topical compositions of fenoldopam | Human Necessities | 0 | Active |
| US11299583B2 | Alternating and semi-alternating poly(ester-anhydride) copolymers | Human Necessities | 0 | Active |
| US11173117B2 | Topical Montelukast formulations | Human Necessities | 0 | Active |
| US10774176B2 | Alternating and semi-alternating poly(ester-anhydride) copolymers | Human Necessities | 0 | Active |
| US11612607B2 | Fenoldopam topical formulations for treating skin disorders | Human Necessities | 0 | Active |
| US12233055B2 | Topical Montelukast formulations | Human Necessities | 0 | Active |
| US10172882B2 | Pharmaceutical compositions comprising ferric citrate and methods for the production thereof | Human Necessities | 0 | Active |
| US11844861B2 | Topical Montelukast formulations | Human Necessities | 0 | Active |
| US11559541B2 | Topical capecitabine for the treatment of hyperproliferative skin conditions | Human Necessities | 0 | Active |
| US11141488B2 | Compositions comprising biodegradable copolymers for prolonged local release of an antibiotic | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.